The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | |||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | ||||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | FIGI | (to the nearest dollar) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
ACLARIS THERAPEUTICS INC | COM | 00461U105 | 133,387 | 19,473 | SH | SOLE | 19,473 | 0 | 0 | |||
ALLAKOS INC | COM | 01671P100 | 111,978 | 49,329 | SH | SOLE | 49,329 | 0 | 0 | |||
APOGEE THERAPEUTICS INC | COM | 03770N101 | 265,653 | 12,472 | SH | SOLE | 12,472 | 0 | 0 | |||
COMPASS THERAPEUTICS INC | COM | 20454B104 | 170,942 | 86,773 | SH | SOLE | 86,773 | 0 | 0 | |||
ELEVATION ONCOLOGY INC | COM | 28623U101 | 14,453 | 21,813 | SH | SOLE | 21,813 | 0 | 0 | |||
MOLECULAR TEMPLATES INC | COM NEW | 608550208 | 864,993 | 136,866 | SH | SOLE | 136,866 | 0 | 0 | |||
REZOLUTE INC | COM NEW | 76200L309 | 1,741,036 | 1,318,967 | SH | SOLE | 1,318,967 | 0 | 0 | |||
SAVARA INC | COM | 805111101 | 12,525,416 | 3,313,602 | SH | SOLE | 3,313,602 | 0 | 0 | |||
XERIS BIOPHARMA HOLDINGS INC | COM | 98422E103 | 10,493,971 | 5,641,920 | SH | SOLE | 5,641,920 | 0 | 0 |